Medical News

RSS
Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Hallam Assistant Dean to head national health and care regulator

Hallam Assistant Dean to head national health and care regulator

Ebola diagnosis now possible within minutes

Ebola diagnosis now possible within minutes

World MRSA Day Kickoff Event and Global C. difficile Summit to be held on September 26, 2015 in Illinois

World MRSA Day Kickoff Event and Global C. difficile Summit to be held on September 26, 2015 in Illinois

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

Novasep to build fully integrated Antibody Drug Conjugate facility at Le Mans site in France

Novasep to build fully integrated Antibody Drug Conjugate facility at Le Mans site in France

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

UAlberta partnership could transform cancer treatment, improve patient outcomes

UAlberta partnership could transform cancer treatment, improve patient outcomes

Impax Laboratories prices convertible senior notes due 2022 in private offering

Impax Laboratories prices convertible senior notes due 2022 in private offering

Studies compare self-reported health between unemployed and working populations

Studies compare self-reported health between unemployed and working populations

New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease

New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease

New initiative aims to determine prevalence of contaminants in Detroit’s urban agriculture soil

New initiative aims to determine prevalence of contaminants in Detroit’s urban agriculture soil

gEHRiMed EHR solution selected by Extended Care Specialists

gEHRiMed EHR solution selected by Extended Care Specialists

ASH: President Obama, U.S. Trade Representative Ambassador have opportunity to curb tobacco epidemic forever

ASH: President Obama, U.S. Trade Representative Ambassador have opportunity to curb tobacco epidemic forever

UK Court passes verdict in favor of Lilly relating to Alimta vitamin regimen patent claim

UK Court passes verdict in favor of Lilly relating to Alimta vitamin regimen patent claim

BUSM recognized with People's Health Medals for advancing hospital nutrition in Vietnam

BUSM recognized with People's Health Medals for advancing hospital nutrition in Vietnam

Weight loss along with vitamin D supplementation reduces chronic inflammation

Weight loss along with vitamin D supplementation reduces chronic inflammation

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

Biontech, Siemens enter into strategic collaboration on manufacture of personalized cancer vaccines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.